Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership


All
13F
13D/G
Other

TAKEDA PHARMACEUTICAL CO LTD (TKPYY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 6-K Quarterly results
09/28/2023 6-K Quarterly results
08/01/2023 6-K Quarterly results
07/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Financial Appendix"
07/12/2023 6-K Quarterly results
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"2023 Annual Integrated Report"
07/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
06/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/26/2023 SC 13D/A TAKEDA PHARMACEUTICAL CO LTD reports a 0% stake in Calithera Biosciences, Inc.
05/26/2023 4 TAKEDA PHARMACEUTICAL CO LTD (Former 10% Owner) has filed a Form 4 on Calithera Biosciences, Inc.
Txns: Disposed of 1,000,000 convertible preferred @ $0
05/17/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/15/2023 SD Form SD - Specialized disclosure report:
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Financial Appendix"
03/30/2023 6-K Quarterly results
03/20/2023 6-K Quarterly results
03/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"QDENGA Investor call Presentation 2023"
03/01/2023 6-K Quarterly results
02/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/07/2023 SC 13G/A BlackRock Inc. reports a 7.2% stake in TAKEDA PHARMACEUTICAL COMPANY LIMITED
02/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Financial Appendix (incorporated by reference to to Form 6-K of the Registrant, filed on February 2, 2023)"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy